# A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy

> **NCT02159690** · PHASE2 · WITHDRAWN · sponsor: **Kenneth Pienta, MD**

## Conditions studied

- Prostate Cancer
- Localized Prostate Cancer

## Interventions

- **DRUG:** Enzalutamide
- **DRUG:** Abiraterone acetate
- **DRUG:** Prednisone
- **DRUG:** Dutasteride
- **DRUG:** Degarelix

## Key facts

- **NCT ID:** NCT02159690
- **Lead sponsor:** Kenneth Pienta, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-09
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** loss of funding
- **Last updated:** 2015-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02159690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02159690, "A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02159690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*